{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:47Z","timestamp":1794047447815,"version":"4.8.0"},"reference-count":50,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"2","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>The t(14;19)(q32;q13) often juxtaposes BCL3 with immunoglobulin heavy chain (IGH) resulting in overexpression of the gene. In contrast to other oncogenic translocations, BCL3 rearrangement (BCL3-R) has been associated with a broad spectrum of lymphoid neoplasms. Here we report an integrative whole-genome sequence, transcriptomic, and DNA methylation analysis of 13 lymphoid neoplasms with BCL3-R. The resolution of the breakpoints at single base-pair revealed that they occur in two clusters at 5\u2019 (n=9) and 3\u2019 (n=4) regions of BCL3 associated with two different biological and clinical entities. Both breakpoints were mediated by aberrant class switch recombination of the IGH locus. However, the 5\u2019 breakpoints (upstream) juxtaposed BCL3 next to an IGH enhancer leading to overexpression of the gene whereas the 3\u2019 breakpoints (downstream) positioned BCL3 outside the influence of the IGH and were not associated with its expression. Upstream BCL3-R tumors had unmutated IGHV, trisomy 12, and mutated genes frequently seen in chronic lymphocytic leukemia (CLL) but had an atypical CLL morphology, immunophenotype, DNA methylome, and expression profile that differ from conventional CLL. In contrast, downstream BCL3-R neoplasms were atypical splenic or nodal marginal zone lymphomas (MZL) with mutated IGHV, complex karyotypes and mutated genes typical of MZL. Two of the latter four tumors transformed to a large B-cell lymphoma. We designed a novel fluorescence in situ hybridization assay that recognizes the two different breakpoints and validated these findings in 17 independent tumors. Overall, upstream or downstream breakpoints of BCL3-R are mainly associated with two subtypes of lymphoid neoplasms with different (epi)genomic, expression, and clinicopathological features resembling atypical CLL and MZL, respectively.<\/jats:p>","DOI":"10.3324\/haematol.2023.283209","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T03:45:57Z","timestamp":1691639157000},"page":"493-508","source":"Crossref","is-referenced-by-count":14,"title":["&lt;i&gt;BCL3&lt;\/i&gt; rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases"],"prefix":"10.3324","volume":"109","author":[{"given":"Anna","family":"Carbo-Meix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Guijarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Royo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Frigola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Playa-Albinyana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco M.","family":"Buhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillem","family":"Clot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marti","family":"Duran-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Granada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Joao","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Tomas","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Espinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Puiggros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bandiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"De Canal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Bonoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fina","family":"Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Ribera-Cortada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Fernandez-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"De la Banda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janilson","family":"Do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rozman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Aymerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Syrykh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrecia","family":"Yanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus Xavier","family":"Ortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Tuset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Zenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose I.","family":"Martin-Subero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Colomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estella","family":"Matutes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Nadeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"57328","doi-asserted-by":"crossref","unstructured":"Michaux L, Mecucci C, Stul M. BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders. Genes Chromosomes Cancer. 1996; 15(1):38-47.","DOI":"10.1002\/(SICI)1098-2264(199601)15:1<38::AID-GCC6>3.0.CO;2-5"},{"key":"57329","doi-asserted-by":"crossref","unstructured":"Palmer S, Chen YH. Bcl-3, a multifaceted modulator of NF-kappaB-mediated gene transcription. Immunol Res. 2008; 42(1\u20133):210-218.","DOI":"10.1007\/s12026-008-8075-4"},{"key":"57330","doi-asserted-by":"crossref","unstructured":"Liu H, Zeng L, Yang Y, Guo C, Wang H. Bcl-3: a double-edged sword in immune cells and inflammation. Front Immunol. 2022; 13:847699.","DOI":"10.3389\/fimmu.2022.847699"},{"key":"57331","doi-asserted-by":"crossref","unstructured":"Zhang X, Paun A, Claudio E, Wang H, Siebenlist U. The tumor promoter and NF-\u03baB modulator Bcl-3 regulates splenic B cell development. J Immunol. 2013; 191(12):5984-5992.","DOI":"10.4049\/jimmunol.1300611"},{"key":"57332","doi-asserted-by":"crossref","unstructured":"Ong ST, Hackbarth ML, Degenstein LC, Baunoch DA, Anastasi J, McKeithan TW. Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice. Oncogene. 1998; 16(18):2333-2343.","DOI":"10.1038\/sj.onc.1201771"},{"key":"57333","doi-asserted-by":"crossref","unstructured":"Soma LA, Gollin SM, Remstein ED. Splenic small B-cell lymphoma with IGH\/BCL3 translocation. Hum Pathol. 2006; 37(2):218-230.","DOI":"10.1016\/j.humpath.2005.09.025"},{"key":"57334","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Subero JI, Ibbotson R, Klapper W. A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation. Leukemia. 2007; 21(7):1532-1544.","DOI":"10.1038\/sj.leu.2404695"},{"key":"57335","doi-asserted-by":"crossref","unstructured":"Kelly RJ, Wright D, Patil K. t(14;19)(q32;q13) incidence and significance in B-cell lymphoproliferative disorders. Br J Haematol. 2008; 141(4):561-563.","DOI":"10.1111\/j.1365-2141.2008.07075.x"},{"key":"57336","doi-asserted-by":"crossref","unstructured":"Huh YO, Schweighofer CD, Ketterling RP. Chronic lymphocytic leukemia with t(14;19)(q32;q13) is characterized by atypical morphologic and immunophenotypic features and distinctive genetic features. Am J Clin Pathol. 2011; 135(5):686-696.","DOI":"10.1309\/AJCPOEFP3SLX6HXJ"},{"key":"57337","doi-asserted-by":"crossref","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-1760.","DOI":"10.1093\/bioinformatics\/btp324"},{"key":"57338","doi-asserted-by":"crossref","unstructured":"Nadeu F, Mas-de-les-Valls R, Navarro A. IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms. Nat Commun. 2020; 11(1):3390.","DOI":"10.1038\/s41467-020-17095-7"},{"key":"57339","doi-asserted-by":"crossref","unstructured":"Brochet X, Lefranc M-P, Giudicelli V. IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 2008; 36(Web Server issue):W503-508.","DOI":"10.1093\/nar\/gkn316"},{"key":"57340","doi-asserted-by":"crossref","unstructured":"Nadeu F, Royo R, Massoni-Badosa R. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. Nat Med. 2022; 28(8):1662-1671.","DOI":"10.1038\/s41591-022-01927-8"},{"key":"57341","doi-asserted-by":"crossref","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"57342","doi-asserted-by":"crossref","unstructured":"Puente XS, Be\u00e0 S, Vald\u00e9s-Mas R. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature. 2015; 526(7574):519-524.","DOI":"10.1038\/nature14666"},{"key":"57343","doi-asserted-by":"crossref","unstructured":"Lu J, Cannizzaro E, Meier-Abt F. Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia. Nat Cancer. 2021; 2(8):853-864.","DOI":"10.1038\/s43018-021-00216-6"},{"key":"57344","doi-asserted-by":"crossref","unstructured":"Ritchie ME, Phipson B, Wu D. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47.","DOI":"10.1093\/nar\/gkv007"},{"key":"57345","doi-asserted-by":"crossref","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014; 30(10):1363-1369.","DOI":"10.1093\/bioinformatics\/btu049"},{"key":"57346","doi-asserted-by":"crossref","unstructured":"Bailey TL, Johnson J, Grant CE, Noble WS. The MEME suite. Nucleic Acids Res. 2015; 43(W1):W39-W49.","DOI":"10.1093\/nar\/gkv416"},{"key":"57347","doi-asserted-by":"crossref","unstructured":"Castro-Mondragon JA, Riudavets-Puig R, Rauluseviciute I. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2022; 50(D1):D165-D173.","DOI":"10.1093\/nar\/gkab1113"},{"key":"57348","doi-asserted-by":"crossref","unstructured":"Ventura RA, Martin-Subero JI, Jones M. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn. 2006; 8(2):141-151.","DOI":"10.2353\/jmoldx.2006.050083"},{"key":"57349","doi-asserted-by":"crossref","unstructured":"Navarro A, Clot G, Mart\u00ednez-Trillos A. Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier. Haematologica. 2017; 102(9):e360-e363.","DOI":"10.3324\/haematol.2016.160374"},{"key":"57350","doi-asserted-by":"crossref","unstructured":"Seifert M, Sellmann L, Bloehdorn J. Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med. 2012; 209(12):2183-2198.","DOI":"10.1084\/jem.20120833"},{"key":"57351","doi-asserted-by":"crossref","unstructured":"Gutierrez A, Tschumper RC, Wu X. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood. 2010; 116(16):2975-2983.","DOI":"10.1182\/blood-2010-02-269878"},{"key":"57352","doi-asserted-by":"crossref","unstructured":"Kulis M, Heath S, Bibikova M. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet. 2012; 44(11):1236-1242.","DOI":"10.1038\/ng.2443"},{"key":"57353","doi-asserted-by":"crossref","unstructured":"Duran-Ferrer M, Clot G, Nadeu F. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome. Nat Cancer. 2020; 1(11):1066-1081.","DOI":"10.1038\/s43018-020-00131-2"},{"key":"57354","doi-asserted-by":"crossref","unstructured":"Griffen TL, Dammer EB, Dill CD. Multivariate transcriptome analysis identifies networks and key drivers of chronic lymphocytic leukemia relapse risk and patient survival. BMC Med Genomics. 2021; 14(1):171.","DOI":"10.1186\/s12920-021-01012-y"},{"key":"57355","doi-asserted-by":"crossref","unstructured":"Pinnell N, Yan R, Cho HJ. The PIAS-like coactivator Zmiz1 is a direct and selective cofactor of Notch1 in T cell development and leukemia. Immunity. 2015; 43(5):870-883.","DOI":"10.1016\/j.immuni.2015.10.007"},{"key":"57356","doi-asserted-by":"crossref","unstructured":"Cook ME, Jarjour NN, Lin C-C, Edelson BT. Transcription factor Bhlhe40 in immunity and autoimmunity. Trends Immunol. 2020; 41(11):1023-1036.","DOI":"10.1016\/j.it.2020.09.002"},{"key":"57357","doi-asserted-by":"crossref","unstructured":"Rauschmeier R, Reinhardt A, Gustafsson C. Bhlhe40 function in activated B and TFH cells restrains the GC reaction and prevents lymphomagenesis. J Exp Med. 2022; 219(2):e20211406.","DOI":"10.1084\/jem.20211406"},{"key":"57358","doi-asserted-by":"crossref","unstructured":"Papakonstantinou N, Ntoufa S, Tsagiopoulou M. Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia. Int J Cancer. 2019; 144(11):2695-2706.","DOI":"10.1002\/ijc.31999"},{"key":"57359","doi-asserted-by":"crossref","unstructured":"Roadcap DW, Clemen CS, Bear JE. The role of mammalian coronins in development and disease. Subcell Biochem. 2008; 48:124-135.","DOI":"10.1007\/978-0-387-09595-0_12"},{"key":"57360","doi-asserted-by":"crossref","unstructured":"Seda V, Vojackova E, Ondrisova L. FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia. Blood. 2021; 138(9):758-772.","DOI":"10.1182\/blood.2020008101"},{"key":"57361","doi-asserted-by":"crossref","unstructured":"Khanna P, Lee JS, Sereemaspun A, Lee H, Baeg GH. GRAMD1B regulates cell migration in breast cancer cells through JAK\/STAT and Akt signaling. Sci Rep. 2018; 8(1):9511.","DOI":"10.1038\/s41598-018-27864-6"},{"key":"57362","doi-asserted-by":"crossref","unstructured":"Hutterer E, Asslaber D, Caldana C. CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms. Br J Haematol. 2015; 169(2):286-289.","DOI":"10.1111\/bjh.13188"},{"key":"57363","doi-asserted-by":"crossref","unstructured":"Goldin LR, McMaster ML, Rotunno M. Whole exome sequencing in families with CLL detects a variant in Integrin \u03b2 2 associated with disease susceptibility. Blood. 2016; 128(18):2261-2263.","DOI":"10.1182\/blood-2016-02-697771"},{"key":"57364","doi-asserted-by":"crossref","unstructured":"Dobashi A, Togashi Y, Tanaka N. TP53 and OSBPL10 alterations in diffuse large B-cell lymphoma: prognostic markers identified via exome analysis of cases with extreme prognosis. Oncotarget. 2018; 9(28):19555-19568.","DOI":"10.18632\/oncotarget.24656"},{"key":"57365","doi-asserted-by":"crossref","unstructured":"Schweighofer CD, Coombes KR, Majewski T. Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes. J Mol Diagn. 2013; 15(2):196-209.","DOI":"10.1016\/j.jmoldx.2012.09.006"},{"key":"57366","doi-asserted-by":"crossref","unstructured":"Grau M, L\u00f3pez C, Navarro A. Unraveling the genetics of transformed splenic marginal zone lymphoma. Blood Adv. 2023; 7(14):3695-3709.","DOI":"10.1182\/bloodadvances.2022009415"},{"key":"57367","doi-asserted-by":"crossref","unstructured":"Oppezzo P, Vuillier F, Vasconcelos Y. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood. 2003; 101(10):4029-4032.","DOI":"10.1182\/blood-2002-10-3175"},{"key":"57368","doi-asserted-by":"crossref","unstructured":"Roco JA, Mesin L, Binder SC. Class-switch recombination occurs infrequently in germinal centers. Immunity. 2019; 51(2):337-350.","DOI":"10.1016\/j.immuni.2019.07.001"},{"key":"57369","doi-asserted-by":"crossref","unstructured":"Bastidas\u2010Mora G, Be\u00e0 S, Navarro A. Clinico\u2010biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation. Br J Haematol. 2022; 196(1):146-155.","DOI":"10.1111\/bjh.17815"},{"key":"57370","doi-asserted-by":"crossref","unstructured":"Otto C, Scholtysik R, Schmitz R. Novel IGH and MYC translocation partners in diffuse large B-cell lymphomas. Genes Chromosomes Cancer. 2016; 55(12):932-943.","DOI":"10.1002\/gcc.22391"},{"key":"57371","doi-asserted-by":"crossref","unstructured":"Almire C, Bertrand P, Ruminy P. PVRL2 is translocated to the TRA@ locus in t(14;19)(q11;q13)-positive peripheral T-cell lymphomas. Genes Chromosomes Cancer. 2007; 46(11):1011-1018.","DOI":"10.1002\/gcc.20490"},{"key":"57372","doi-asserted-by":"crossref","unstructured":"Chapiro E, Radford-Weiss I, Bastard C. The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia. Leukemia. 2008; 22(11):2123-2127.","DOI":"10.1038\/leu.2008.102"},{"key":"57373","doi-asserted-by":"crossref","unstructured":"Salido M, Bar\u00f3 C, Oscier D. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood. 2010; 116(9):1479-1488.","DOI":"10.1182\/blood-2010-02-267476"},{"key":"57374","doi-asserted-by":"crossref","unstructured":"Busschots AM, Mecucci C, Stul M. Translocation (14;19)(q32;q13.1) in a young patient who developed a large cell lymphoma after an initial diagnosis of CLL. Leuk Lymphoma. 1991; 5(4):281-286.","DOI":"10.3109\/10428199109068138"},{"key":"57375","doi-asserted-by":"crossref","unstructured":"Michaux L, Dierlamm J, Wlodarska I, Bours V, Van Den Berghe H, Hagemeijer A. t(14;19)\/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases. Cancer Genet Cytogenet. 1997; 94(1):36-43.","DOI":"10.1016\/S0165-4608(96)00247-6"},{"key":"57376","doi-asserted-by":"crossref","unstructured":"Fang H, Reichard KK, Rabe KG. IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes. Am J Hematol. 2019; 94(3):338-345.","DOI":"10.1002\/ajh.25385"},{"key":"57377","doi-asserted-by":"crossref","unstructured":"Rossi D, Deambrogi C, Monti S. BCL3 translocation in CLL with typical phenotype: assessment of frequency, association with cytogenetic subgroups, and prognostic significance. Br J Haematol. 2010; 150(6):702-704.","DOI":"10.1111\/j.1365-2141.2010.08255.x"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283209\/75947","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283209\/76540","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11199\/75947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:04:38Z","timestamp":1794045878000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283209","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,10]]}}}